Q1 2026 Definium Therapeutics Inc Earnings Call Transcript
Good afternoon. I'm Geeta Jain, Head of Investor Relations, and thank you for joining us today for Devinium Therapeutics' First Quarter 2026 Financial Results and Recent Highlights Conference Call.
Currently, all participants are in listen-only mode. This webcast is live on the Investors section of Definium's website at definiumtx.com, and a replay will be available after the webcast.
Leading the call today will be Rob Barrow, our Chief Executive Officer, who is joined by Dr. Dan Carlin, our Chief Medical Officer, Brandy Roberts, our Chief Financial Officer, and Matt Wiley, our Chief Commercial Officer.
During today's call, we will be making certain forward-looking statements, including, without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, our anticipated cash runaway, and our future expectations, plans, partnerships, and prospects.
These statements are subject to various risks, such as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
